Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pediacel booster versus Infanrix hexa booster with concomitant Prevenar in toddlers
2006-000898-30Phase 3Completed
- Sponsor
- Sanofi
- Start
- Apr 2006
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of diphtheria toxoid + tetanus toxoid + acellular pertussis vaccine + inactivated poliovirus vaccine + haemophilus influenzae type b conjugate vaccine, pertussis filamentous haemagglutinin and pneumococcal 7-valent conjugate vaccine in diphtheria, Tetanus, pertussis and 4 more (2 arms), sponsored by Sanofi. Primary endpoints: Fever rate within 4 days after booster vaccination and Comparative fever incidence. Started Apr 2006; status: completed.
02
Drugs
diphtheria toxoid + tetanus toxoid + acellular pertussis vaccine + inactivated poliovirus vaccine + haemophilus influenzae type b conjugate vaccinepertussis filamentous haemagglutininpneumococcal 7-valent conjugate vaccine
03
Conditions
diphtheriaTetanuspertussispoliomyelitisHaemophilus influenzae type b disease (Hib)
Beyond the preview
Go deeper on 2006-000898-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000898-30.